& Kuca, K
Weight loss typically starts becoming noticeable, appetite suppression increases, and blood sugar regulation improves significantly for those with insulin resistance
Obesity has impacts on cardiovascular disease outcomes through increased risk of coronary artery disease, heart failure (more prominent with preserved ejection fraction), cardiac arrhythmias (most significantly atrial fibrillation), sudden death, and venous thromboembolism [7]
A similar pattern was observed for the LCLT and placebo groups when comparing days 1 and 14 ( p = 0.018, p = 0.013, respectively)
In order to evaluate the mechanisms of action of tirzipatide, in a recent study [62] subjects with T2DM performed a deep metabolic evaluation with measures of beta cell function and insulin sensitivity by hyperglycemic clamp, mixed meal test and euglycemic clamp before and 28 weeks after treatment with tirzepatide 15 mg or semaglutide 1 mg